chr12-32877909-GCCT-AGGC
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001005242.3(PKP2):c.968_971inv(p.Gln323_Ala324delinsArgLeu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
PKP2
NM_001005242.3 missense
NM_001005242.3 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.46
Genes affected
PKP2 (HGNC:9024): (plakophilin 2) This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene may regulate the signaling activity of beta-catenin and is required to maintain transcription of genes that control intracellular calcium cycling including ryanodine receptor 2, ankyrin-B, triadin, and calcium channel, voltage-dependent, L type, alpha 1C. Mutations in this gene are associated with different inherited cardiac conditions including Arrythmogenic Cardiomyopathy, Brugada Syndrome, and Idiopathic Ventricular Fibrillation. A processed pseudogene with high similarity to this gene has been mapped to chromosome 12p13. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKP2 | NM_001005242.3 | c.968_971inv | p.Gln323_Ala324delinsArgLeu | missense_variant | 3/13 | ENST00000340811.9 | NP_001005242.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKP2 | ENST00000340811.9 | c.968_971inv | p.Gln323_Ala324delinsArgLeu | missense_variant | 3/13 | 1 | NM_001005242.3 | ENSP00000342800 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 22, 2023 | This variant, c.968_971delinsGCCT, is a complex sequence change that results in the deletion of 2 and insertion of 2 amino acid(s) in the PKP2 protein (p.Gln323_Ala324delinsArgLeu). This variant is present in population databases (rs745882420, gnomAD 0.02%). This variant has been observed in individual(s) with clinical features of arrhythmogenic cardiomyopathy (PMID: 34120153). ClinVar contains an entry for this variant (Variation ID: 1693192). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 13, 2021 | - - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 08, 2024 | This variant changes two consecutive amino acids of the PKP2 protein (p.Gln323Arg and p.Ala324Leu). To our knowledge, functional studies have not been reported for this variant. This variant was identified in 41 individuals from a control group, none of whom had diagnoses related to arrhythmogenic cardiomyopathy (PMID: 34120153). This variant has been identified in 12/281568 chromosomes in the general population by the Genome Aggregation Database (gnomAD) (PMID: 34120153). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Aug 08, 2023 | - - |
PKP2-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 26, 2024 | The PKP2 c.968_971delinsGCCT variant is predicted to result in an in-frame deletion and insertion. This variant was reported in an individual with cardiomyopathy (Dries et al. 2021. PubMed ID: 34120153). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 28, 2022 | Reported in association with cardiomyopathy in published literature (Dries et al., 2021); In silico analysis supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 34120153) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.968_971delAGGCinsGCCT variant (also known as p.Q323_A324delinsRL), located in coding exon 3 of the PKP2 gene, results from an in-frame deletion of AGGC and insertion of GCCT at nucleotide positions 968 to 971. This results in the substitution of glutamine and alanine residues for arginine and leucine residues at codons 323 and 324. This variant has been reported in non-arrhythmogenic cardiomyopathy control individuals from a PKP2 study cohort (Dries AM et al. Genet Med, 2021 Oct;23:1961-1968). These amino acid positions are not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at